PPT-Figure i.1 Trends in the adjusted* incidence rate (per million/year) of ESRD

bars scale on right and annual change in the adjusted incidence rate of ESRD lines scale on left in the US population 19962013 Vol 2 ESRD Intro 2 Data Source Reference Table A22 and special analyses USRDS ESRD Database Adjusted for age sex and race. Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 5.1 Adjusted all-cause mortality by treatment modality (a) overall, dialysis, and transplant, and (b) hemodialysis and peritoneal dialysis, for period-prevalent patients, 2001-2015 . vol. 2 Figure 5.1 Adjusted all-cause mortality rates, overall and by modality. Vol. 2, ESRD, . Ch. 5. 3. Data Source: Reference Tables H.4, H.8, H.9, and H.10, and special analyses, USRDS ESRD Database. Adjusted for age, sex, race, and primary diagnosis. Ref: 2011 patients. Abbreviation: ESRD, end-stage renal disease.. 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol. . 2 Figure . 4.. 1. . Adjusted . hospitalization rates for ESRD patients, by treatment modality, 2006-2015. Data . Source: Reference Tables G.1, G.3, G.4, G.5, G.6, G.8, G.9, G.10, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, primary cause of kidney failure, & their two-way interactions; standard population: ESRD patients, 2011. Abbreviation: ESRD, end-stage renal . 2016 Annual Data Report, Vol . 2, ESRD. , . Ch. . 5. 2. Data Source. : Reference . Tables G.1, G.3, G.4, G.5, G.6, G.8, G.9, G.10, and special analyses, USRDS ESRD Database. Period prevalent ESRD patients; adjusted for age, sex, race, primary cause of kidney failure & their two-way interactions; reference group, ESRD patients, 2011. Abbreviation: ESRD, end-stage renal disease.. dialysis; . Tx. , transplant. . v. ol. . 2 Figure . 7.1. Incident & December 31 point prevalent ESRD patients (. aged 0-19 years). (a) Incidence . of ESRD in . children. Vol. 2, ESRD, . Ch. 7. Figure 6.1.a Adjusted all-cause mortality (deaths per 1,000 patient-years) by treatment modality: overall, dialysis, and transplant for period-prevalent patients, 1996-2014 2016 Annual Data Report, Vol 2017 . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol. . 2. . Figure. . 11.1. . Geographic. . variations. . in. . the. . incidence. . rate. . of. . treated. . ESRD. . (per. 463 Chapter 7 : ESRD among Children, Adolescents, and Young Adults  The number of children and adolescents beginning end - stage renal disease ( ESRD ) care is steadily decreasing from a high Tx. , transplant.. Figure . 8.1 . Number of (a) incident and (b) December 31 point prevalent ESRD . pediatric . patients (aged 0–21 years), by modality, 1996-2013. Vol 2, ESRD, . Ch. 8. 2. Incident. vol. 2 . Figure 1.1 Trends in the number of incident cases of ESRD, in thousands, by modality, in the U.S. population, 1980-2012. Vol. 2, ESRD, . Ch. 1. 2. Data Source: Reference tables A.2(2) and A.2(3). *Adjusted for age, sex, and race. The standard population was the U.S. population in 2011. Abbreviation: ESRD, end-stage renal disease.. Goris M, Boer KR, Duarte T, Kliffen SJ, Hartskeerl RA. Human Leptospirosis Trends, the Netherlands, 1925–2008. Emerg Infect Dis. 2013;19(3):371-378. https://doi.org/10.3201/eid1903.111260. Lihua. Liu, PhD . Juanjuan. Zhang, MS. Dennis . Deapen. , . DrPH. Los Angeles Cancer Surveillance Program. University of Southern California. Los Angeles County, California. Source: 2006-2008 American Community Survey 3-year estimates. United States Renal Data System. 2012 Annual Data Report. Adjusted all-cause rehospitalization . rates in pediatric patients 30 days . after live hospital discharge. Figure 8.1 (Volume 2). ESRD patients age 0–19. . Annual Data Report. Volume 2: End-Stage Renal Disease. 2. vol 2 Figure 5.1 Adjusted all-cause mortality by treatment modality (a) overall, dialysis, and transplant, and (b) hemodialysis and peritoneal dialysis, for period-prevalent patients,...